Is it time to include vancomycin for routine perioperative antibiotic prophylaxis in total joint arthroplasty patients?

[1]  J. Parvizi,et al.  New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection Society , 2011, Clinical orthopaedics and related research.

[2]  S. Odum,et al.  The Chitranjan Ranawat Award: Fate of Two-stage Reimplantation After Failed Irrigation and Débridement for Periprosthetic Knee Infection , 2011, Clinical orthopaedics and related research.

[3]  E. Tacconelli,et al.  Prosthetic joint infection: recent developments in diagnosis and management. , 2010, The Journal of infection.

[4]  J. Parvizi,et al.  Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. , 2010, The Journal of arthroplasty.

[5]  J. Parvizi,et al.  Periprosthetic joint infection: the economic impact of methicillin-resistant infections. , 2010, The Journal of arthroplasty.

[6]  Daniel Berry,et al.  Prosthetic Joint Infection Risk after TKA in the Medicare Population , 2010, Clinical orthopaedics and related research.

[7]  Hien H. Nguyen,et al.  Prophylactic antibiotics in hip and knee arthroplasty. , 2009, The Journal of bone and joint surgery. American volume.

[8]  J. Parvizi,et al.  The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. , 2009, The Journal of arthroplasty.

[9]  S. Kurtz,et al.  Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. , 2009, The Journal of arthroplasty.

[10]  H. Geiss,et al.  Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA. , 2009, Die Pharmazie.

[11]  G. Maira,et al.  Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. , 2008, The Journal of hospital infection.

[12]  J. Kluytmans,et al.  New approaches to prevention of staphylococcal infection in surgery , 2008, Current opinion in infectious diseases.

[13]  L. Prokuski.  Prophylactic antibiotics in orthopaedic surgery. , 2008, The Journal of the American Academy of Orthopaedic Surgeons.

[14]  Hugo Sax,et al.  Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. , 2008, JAMA.

[15]  A. Rosenstein,et al.  Infection prevention in total knee and total hip arthroplasties. , 2008, American journal of orthopedics.

[16]  B. Davis,et al.  Interrupted Time Series Analysis of Vancomycin Compared to Cefuroxime for Surgical Prophylaxis in Patients Undergoing Cardiac Surgery , 2007, Antimicrobial Agents and Chemotherapy.

[17]  V. Sérazin,et al.  Comparison of Routine Prophylaxis With Vancomycin or Cefazolin for Femoral Neck Fracture Surgery: Microbiological and Clinical Outcomes , 2006, Infection Control & Hospital Epidemiology.

[18]  Brent T. Wise,et al.  Antibiotic susceptibility of bacteria infecting total joint arthroplasty sites. , 2006, The Journal of bone and joint surgery. American volume.

[19]  D. Stevens.  The role of vancomycin in the treatment paradigm. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Robin Patel,et al.  Phenotypic and Genotypic Mupirocin Resistance among Staphylococci Causing Prosthetic Joint Infection , 2005, Journal of Clinical Microbiology.

[21]  J. Lonner,et al.  Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. , 2003, The Journal of arthroplasty.

[22]  A. van Belkum,et al.  Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  R. Wenzel,et al.  Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. , 2002, The New England journal of medicine.

[24]  S. Milo,et al.  Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. , 2002, The Journal of thoracic and cardiovascular surgery.

[25]  M H Samore,et al.  Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. , 2000, Circulation.

[26]  M. Nanni,et al.  Vancomycin prophylaxis in joint arthroplasty. , 1999, La Chirurgia degli Organi di Movimento.

[27]  W. Harmsen,et al.  Risk factors for prosthetic joint infection: case-control study. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  P. Pellicci,et al.  Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. , 1994, Clinical orthopaedics and related research.

[29]  T. Fehring,et al.  Periprosthetic knee sepsis. The role of irrigation and debridement. , 1991, Clinical orthopaedics and related research.

[30]  M. Ritter,et al.  Vancomycin prophylaxis and elective total joint arthroplasty. , 1989, Orthopedics.

[31]  J. Evrard,et al.  PROPHYLACTIC CEFAZOLIN VERSUS PLACEBO IN TOTAL HIP REPLACEMENT Report of a Multicentre Double-blind Randomised Trial , 1981, The Lancet.

[32]  L. Lidgren,et al.  Prophylactic antibiotics against early and late deep infections after total hip replacements. , 1977, Acta orthopaedica Scandinavica.

[33]  F. J. Ensell,et al.  ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.